Eton Pharmaceuticals, Inc. (ETON)
Pharmaceutical Preparations
Latest Price
$46.42
TTM P/E
--
Normalized P/E
2.23
Div Yield
--
Book Value
1.12
P/B Ratio
41.37
Valuation metrics
adjust assumptions →Base FCF: $6M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$16.11
65% downside
Institutional Ownership
63.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2.86M | $70.0M | 10.45% | -- | 2026-03-31 |
| EcoR1 Capital, LLC | 2.17M | $53.0M | 7.94% | +141.4K | 2026-03-31 |
| BlackRock, Inc. | 1.72M | $42.0M | 6.28% | -21.6K | 2026-03-31 |
| Nantahala Capital Management, LLC | 1.18M | $29.0M | 4.30% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 994.1K | $24.0M | 3.63% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 577.7K | $14.0M | 2.11% | +12.6K | 2026-03-31 |
| STATE STREET CORP | 530.2K | $13.0M | 1.94% | +28.3K | 2026-03-31 |
| National Philanthropic Trust | 492.1K | $12.0M | 1.80% | -- | 2026-03-31 |
| MORGAN STANLEY | 478.0K | $11.0M | 1.75% | -16.0K | 2026-03-31 |
| Westside Investment Management, Inc. | 467.9K | $11.0M | 1.71% | -3.0K | 2026-03-31 |